Infectologia
Breve revisão | O intestino na COVID-19.
16 Jul, 2021 | 09:54hThe gut in COVID-19 – Intensive Care Medicine
Comentário no Twitter
Gut & #COVID19, main findings
➡️clinical GI features
➡️pathophysiology: cytotoxic enterocyte injury, microvascular injury/thromboinfammation, non‑specifc critical illness‑related dysfunction
➡️GI dysfunction in severe #SARSCoV2 vs other critical illnesseshttps://t.co/wzzTNldInN pic.twitter.com/DnHLMsSu6v— Intens Care Med (@yourICM) July 9, 2021
Diretriz AAFP | Tratamento farmacológico das exacerbações de doença pulmonar obstrutiva crônica (DPOC).
16 Jul, 2021 | 09:49hAlém do coronavírus: descobertas sobre os vírus transformando a biologia – “SARS-CoV-2 é apenas 1 de incontáveis vírus em nosso planeta, e os cientistas estão identificando rapidamente legiões de novas espécies.”
16 Jul, 2021 | 09:44hBeyond coronavirus: the virus discoveries transforming biology – Nature
Comentário no Twitter
.@Nature reports how over the past 10 years, the number of known and named viruses has exploded, owing to advances in the technology for finding them, plus a recent change to the rules for identifying new species. https://t.co/lGqrpOWBsB
— Nature Portfolio (@NaturePortfolio) July 3, 2021
Estudo randomizado | Banlanivimabe com etesevimabe reduz a mortalidade e a hospitalização em pacientes ambulatoriais com início de Covid-19 (até 3 dias de um teste positivo) que estão sob risco de piora clínica (p.ex., idosos, obesos, diabéticos, imunocomprometidos, portadores de doença cardiovascular).
15 Jul, 2021 | 10:41hBamlanivimab plus Etesevimab in Mild or Moderate Covid-19 – New England Journal of Medicine
Estudo sugere que milhões de crianças pelo mundo interromperam as rotinas de vacinação durante a pandemia.
15 Jul, 2021 | 10:40hMillions of children worldwide missed routine vaccinations during the pandemic, study suggests – CNN
Estudo original: Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study – The Lancet
Comentário convidado: Disruptions to childhood immunisation due to the COVID-19 pandemic – The Lancet
“Long COVID” e crianças: cientistas correm para encontrar respostas – “Crianças também apresentam ‘long COVID’, mas os pesquisadores ainda estão trabalhando para determinar qual a frequência e a gravidade.”
15 Jul, 2021 | 10:38hLong COVID and kids: scientists race to find answers – Nature
Estudo mostra que a carga viral nas infecções pela variante Delta é cerca de 1.000 vezes mais alta do que nas infecções por cepas anteriores.
15 Jul, 2021 | 10:36hComentário: The Delta Variant Isn’t Just Hyper-Contagious. It Also Grows More Rapidly Inside You – NPR
Relacionado: WHO: Delta variant is ‘most transmissible’ identified so far. E Increased transmissibility and global spread of SARS-CoV-2 variants of concern – “Estimated transmissibility increases of alpha 29% (95% CI: 24–33), beta 25% (95% CI: 20–30), gamma 38% (95% CI: 29–48) & delta 97% (95% CI: 76–117)”.
Comentário no Twitter
Part of the challenge that Delta presents may be tied to this finding
The variant's viral load ~1,000X higher than previous strains (reflected by low CTs), more infectious in the early stages of the illnesshttps://t.co/09CDQFwCSV pic.twitter.com/mjIfcNTYlO— Eric Topol (@EricTopol) July 9, 2021
COVID e o cérebro: pesquisadores estão encontrando respostas sobre como o dano acontece.
15 Jul, 2021 | 10:35hCOVID and the brain: researchers zero in on how damage occurs – Nature
[Preprint] Imagens cerebrais antes e após COVID-19 no Biobank do Reino Unido.
15 Jul, 2021 | 10:34hBrain imaging before and after COVID-19 in UK Biobank – medRxiv
Comentários: COVID linked to loss of brain tissue: but correlation doesn’t prove causation – The Conversation E COVID-19 survivors may suffer from a loss of gray matter and other brain tissue over time, a long-term study suggests – Business Insider
OMS lança a primeira diretriz global para validação dos países sobre eliminação das hepatites virais B e C.
15 Jul, 2021 | 10:33hComunicado de imprensa: WHO releases first-ever global guidance for country validation of viral hepatitis B and C elimination – World Health Organization
Ver diretriz: Interim guidance for country validation of viral hepatitis elimination – World Health Organization